CLEAR-CELL METASTATIC RENAL CELL CARCINOMA
Clinical trials for CLEAR-CELL METASTATIC RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CLEAR-CELL METASTATIC RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for CLEAR-CELL METASTATIC RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced kidney cancer: experimental drug enters human trials
Disease control Recruiting nowThis study tests a new medicine, PF-08634404, in adults with advanced kidney cancer that has spread. The goal is to see if the drug is safe and can shrink tumors when used alone or with other cancer drugs. About 224 participants who have not had prior treatment for their advanced…
Matched conditions: CLEAR-CELL METASTATIC RENAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could a simple dose change make a tough cancer drug easier to take?
Disease control Recruiting nowThis Phase II trial is testing whether a different dosing schedule of the drug cabozantinib can reduce side effects while still controlling cancer growth. It includes people with advanced kidney cancer (clear cell or non-clear cell) and neuroendocrine tumors (including carcinoid)…
Matched conditions: CLEAR-CELL METASTATIC RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC